Twitter

Archive for January 20th, 2012


Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma

Condition :   Advanced Renal Cell Carcinoma Intervention :   Drug: Pazopanib + interferon alpha 2A Sponsors :   Spanish Oncology Genito-Urinary Group;   GlaxoSmithKline Recruiting – verified April 2010

Read More...

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

Conditions :   Acute Lymphoblastic Leukemia;   Lymphoblastic Lymphoma;   Burkitts Leukemia/Lymphoma;   Chronic Myelogenous Leukemia Interventions :   Drug: CLAG-M;   Drug: CLAG-M Sponsor :   New York Medical College Recruiting – verified January 2012

Read More...

Effectiveness of Methylene Blue Guidance in Total Excision of Pilonidal Sinus.

Condition :   Pilonidal Sinus Intervention :   Procedure: Pilonidal sinus excision Sponsor :   Bezmialem Vakif University Not yet recruiting – verified January 2012

Read More...

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

Condition :   Rosacea Interventions :   Drug: Metronidazole Topical Gel 1%;   Drug: Metronidazole Topical Gel 1% (Metrogel);   Drug: Placebo Sponsor :   Taro Pharmaceuticals USA Recruiting – verified January 2012

Read More...

A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction

Condition :   Jaundice Interventions :   Procedure: EUS-FNA first, followed by CRCP with bilinary stenting;   Procedure: ERCP with stent placement, followed by EUS-FNA Sponsor :   Comprehensive Cancer Center of Wake Forest University Recruiting – verified January 2012

Read More...

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Conditions :   Neoplasms;   Cancer Interventions :   Drug: VGX-100;   Drug: Bevacizumab Sponsor :   Circadian Technologies Ltd. Recruiting – verified January 2012

Read More...

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Condition :   Breast Cancer Intervention :   Drug: trastuzumab emtansine Sponsor :   Hoffmann-La Roche Not yet recruiting – verified January 2012

Read More...

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Conditions :   Acute Myelogenous Leukemia;   Myeloid Leukemia in Remission;   Effects of Immunotherapy Intervention :   Biological: Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) Sponsor :   Jules Bordet Institute Recruiting – verified January 2012

Read More...

The Gastric Cancer Foundation: A Gastric Cancer Registry

Condition :   Gastric Cancer Intervention :   Sponsor :   Stanford University Recruiting – verified January 2012

Read More...

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

Condition :   Breast Cancer Intervention :   Other: immunohistochemical dectection of lymphocytes T CD8+/Foxp3 ratio Sponsor :   Centre Georges Francois Leclerc Not yet recruiting – verified January 2012

Read More...